PhRMA
FEBRUARY 11, 2025
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The PhRMA blog welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view.
Pharmacy Times
FEBRUARY 20, 2025
Panelists discuss how pharmacists play a crucial role in optimizing health outcomes for women with complex health needs through comprehensive medication management, personalized consultations, and interdisciplinary collaboration. They provide targeted medication therapy, monitor drug interactions, offer medication counseling, manage chronic conditions, support reproductive health, and help patients navigate complex treatment regimens with expertise and compassionate care.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Checkup by Singlecare
FEBRUARY 4, 2025
Farxiga and Jardiance are two brand-name oral medications approved by the U.S. Food and Drug Administration (FDA) to manage Type 2 diabetes mellitus. Both are sodium-glucose cotransporter 2 (SGLT2) inhibitors. Farxiga, manufactured by AstraZeneca, contains the active drug dapagliflozin, and Jardiance, manufactured by Boehringer Ingelheim Pharmaceuticals, contains the active drug empagliflozin.
PharmD Live
FEBRUARY 12, 2025
As healthcare shifts toward value-based care, medication reconciliation has become a critical focus for reducing costs and improving patient outcomes. Discrepancies in medication regimens, particularly during care transitions like hospital discharge, are a leading cause of adverse drug events (ADEs). These preventable issues result in significant financial burdens on healthcare systems while compromising patient safety and care quality.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
FEBRUARY 20, 2025
In ongoing trials of Eli Lilly’s next-generation obesity drug, several trial participants are running into an issue they never expected: They are losing too much weight. One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs like Wegovy or Zepbound. Her weight dropped so much that researchers reduced her dose of the treatment, called retatrutide.
Pharma Marketing Network
FEBRUARY 17, 2025
Introduction In an era dominated by digital marketing, traditional advertising remains a vital tool for pharma companies to connect with healthcare professionals (HCPs) and patients alike. While online platforms grow, traditional channels such as print ads, TV commercials, and conferences continue to play a crucial role in boosting brand visibility and driving meaningful engagement.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
European Pharmaceutical Review
FEBRUARY 26, 2025
A study has demonstrated a new approach to prepare tablets for intestinal drug delivery by combining two 3D printing techniques. Using both selective laser sintering (SLS) and fused deposition modelling (FDM), the technique has potential to achieve delayed and prolonged drug release, according to the findings. Key findings from the 3D printing drug delivery study [a] laser speed of 90 mm s1 was suitable for producing [3D printed tablet] cores with relatively short disintegration time and suffici
The Checkup by Singlecare
FEBRUARY 24, 2025
Blood thinners are prescription drugs that keep your blood from thickening or clumping, preventing potentially life-threatening blood clots. They include anticoagulant and antiplatelet medications like heparins , Coumadin ( warfarin ), and aspirin , as well as newer-generation anticoagulants like Eliquis (apixaban) and Xarelto (rivaroxaban). Although they dont actually make your blood thinner, these medications reduce your bodys normal blood clotting response to prevent existing blood clots from
IDStewardship
FEBRUARY 12, 2025
In this article an infectious diseases pharmacist discusses important information to know about antibiotic minimum inhibitory concentrations. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article posted12 February 2024 An antibiotic’s minimum inhibitory concentrations (MIC) is the lowest drugconcentration that prevents visible growth of a standard inoculum of a microorganism after ~24 hours of incubation.
STAT
FEBRUARY 3, 2025
People with celiac disease face a food paradox. Gluten-free bagels, brownie mixes, and frozen burritos beckon from grocery store shelves. Yet despite this abundance, they can’t trust that these foods are actually safe to eat. The story of how the food industry went gaga for gluten-free products, putting the health of people with celiac at risk in the process, takes center stage in Emily Abel’s new book, “Gluten Free for Life: Celiac Disease, Medical Recognition, and the Food
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
PharmD Live
FEBRUARY 26, 2025
As specialty medications revolutionize treatment for chronic and complex conditions, their rising costs and intricate management requirements place a significant strain on patients, payers and providers. Without structured oversight, adherence issues, adverse drug interactions and financial barriers can lead to poor outcomes and unnecessary healthcare costs.
DiversifyRx
FEBRUARY 4, 2025
Your pharmacy team will either be your greatest strength or your weakest link. Pharmacy Team development is a critical pillar for independent pharmacy owners aiming to enhance operational efficiency, boost employee satisfaction, and improve patient care. Investing in your team’s growth fosters a positive work environment and directly contributes to your pharmacy’s success.
European Pharmaceutical Review
FEBRUARY 3, 2025
The US Food and Drug Administration (FDA) has sent a warning letter to KVK-Techs drug manufacturing facility following an inspection in April 2019. The document identified significant violations of current good manufacturing practice (cGMP) regulations for finished pharmaceuticals. The FDA issued the warning letter to KVK-Tech in February 2020, advising that due to these cGMP breaches, the companys products are adulterated according to the Federal Food, Drug, and Cosmetic Act (FD&C Act).
The Checkup by Singlecare
FEBRUARY 17, 2025
Many people are turning to compounded versions of semaglutide for various reasons, such as costs and shortages of approved medications like Ozempic and Wegovy. While compounding alternatives might seem appealing, they lack the testing and quality control of their approved counterparts. The side effects of compounded semaglutide can range from mild digestive issues to more severe complications, like low blood sugar (hypoglycemia) or gallbladder problems.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Marketing Network
FEBRUARY 17, 2025
Introduction: In 2025, programmatic advertising will continue to redefine how pharmaceutical brands reach healthcare providers (HCPs) and patients. For pharma marketing teams, staying ahead of programmatic advertising trends is not just importantits essential for success. But what trends will shape the future, and how can your team leverage them to drive results?
STAT
FEBRUARY 20, 2025
Change has come to the Department of Health and Human Services. With the confirmation of Robert F. Kennedy Jr. as secretary, major shifts in organizational structure, staffing , and policy priorities across the department are already underway. But not all HHS agencies are created equal, and some deserve to be modified with a scalpel rather than a sledgehammer.
Pharmacy Times
FEBRUARY 13, 2025
Panelists discuss how menopause marks a significant life transition, characterized by hormonal decline, reproduction cessation, and unique physiological changes requiring medical and emotional support. Health care professionals guide women through lifes reproductive stages, providing comprehensive health care from menarche to post menopause, focusing on individualized prevention of symptom management, and holistic well-being across hormonal transitions.
Pharmafile
FEBRUARY 17, 2025
Recce Pharmaceuticals have announced positive patient data from its phase 2 clinical trial into RECCE 327 (R327), for the treatment of acute bacterial skin and skin structure infections (ABSSSIs), including diabetic foot infections (DFI). R327, a broad-spectrum antibiotic topical gel, was tested in a phase 2 open-label trial that evaluated its safety, tolerability, efficacy and […] The post Recce Pharmaceuticals reports positive phase 2 data for skin infection drug appeared first on Pharma
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
European Pharmaceutical Review
FEBRUARY 17, 2025
The UK government has announced that the Apprenticeship Levy will be replaced by a new Growth and Skills Levy, a move designed to give employers greater control over workforce training. This change aims to address long-standing concerns that the previous system was too rigid, restricting funding primarily to apprenticeships and limiting investment in other essential training programmes.
The Checkup by Singlecare
FEBRUARY 4, 2025
If you have a stubborn bacterial infection, your healthcare provider may prescribe a potent antibiotic like the brand-name medication Bactrim. Bactrim (sulfamethoxazole-trimethoprim), which contains the same activ e ingredients as Septra, is a sulfonamide antibiotic commonly used to treat urinary tract infections, traveler’s diarrhea, middle ear infections, bronchitis, and severe forms of pneumonia known as pneumocystis jirovecii and pneumocystis carinii pneumonia.
Pharma Marketing Network
FEBRUARY 17, 2025
Introduction: In the crowded and competitive world of healthcare, how can your brand stand out? Successful pharmaceutical branding is more than just logos and slogansits about building trust, creating loyalty, and differentiating your brand in the market. Patients, providers, and stakeholders alike choose brands they trust. But earning that trust takes strategic branding that goes beyond marketingit requires authenticity, clarity, and consistency.
STAT
FEBRUARY 3, 2025
Women’s health champions like us cheered in January when the U.S. Preventive Services Task Force (USPSTF) issued a draft recommendation for cervical cancer screening for high-risk genotypes of human papillomavirus (HPV), including the use of self-collection tests. The move follows the Food and Drug Administration’s approval of self-collection tests last summer.
Med Ed 101
FEBRUARY 23, 2025
Fluoroquinolones are broad-spectrum antibiotics used to treat a wide variety of bacterial infections. However, they have a long list of medication interactions that require careful consideration when prescribing and counseling. In this blog post, I will highlight my top 5 fluoroquinolone drug interactions that will likely appear in your practice or on your board exams. […] The post Top 5 Fluoroquinolone Drug Interactions appeared first on Med Ed 101.
Pharmafile
FEBRUARY 3, 2025
The European Commission has announced the opening of a new Biotech and Biomanufacturing Hub, supporting start-ups and small- to medium-sized enterprises (SMEs) in bringing new innovations to the EU market. The Hub, hosted on the EU Commissions Your Europe portal, is in all EU languages and explains such things as: the sources of EU funding […] The post European Commission launches new Biotech and Biomanufacturing Hub appeared first on Pharmafile.
European Pharmaceutical Review
FEBRUARY 13, 2025
New analysis by VTT Technical Research Centre of Finland has highlighted the EUs completely underestimated costs of the newly enforced Urban Wastewater Treatment Directive. Based on the new cost estimates, pharmaceutical manufacturers in Finland alone will be required to fund 280816 million of these expenses, The directive , enforced on 1 January 2025, imposes an extended manufacturer responsibility on the removal of micro-pollutants from wastewaters.
The Checkup by Singlecare
FEBRUARY 25, 2025
Linzess (linaclotide) is a brand-name medication that has long been FDA approved to treat chronic constipation from irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). In 2023, the FDA also approved Linzess as the first treatment for pediatric functional constipation, a condition in children and adolescents that causes infrequent bowel movements and hard stools that are difficult to pass.
PQA
FEBRUARY 28, 2025
PQA is dedicated to improving safe, effective and appropriate medication use and addressing issues that impact a persons ability to access and use medications. As we work to address health equity and social determinants of health that affect medication use quality and patient outcomes, we believe that a diverse, equitable and inclusive workforce will strengthen PQAs efforts.
STAT
FEBRUARY 12, 2025
Where is DeepMind’s AI protein design spinout? The Alphabet-owned AI company took the biology world by storm in 2020 with AlphaFold2 , the protein structure prediction AI platform that “solved” a decades-old biology problem. In 2021, the company spun out Isomorphic Labs, an AI drug discovery company. But Isomorphic’s initial focus is on small-molecule drug discovery, with protein-based drugs remaining a distant twinkle in the company’s eye.
The FDA Law Blog
FEBRUARY 2, 2025
By Sara M Keup In reviewing some new 2025 pharmacy rules/laws a couple interesting changes caught this bloggers attention: As of December 30, 2024, Missouri has rolled out new rules related to prescription drug delivery requirements. The rules were implemented to enhance patient safety protections via revised drug handling, packaging, and delivery requirements.
Pharma Marketing Network
FEBRUARY 27, 2025
Introduction In todays fast-paced world, pharma digital marketing is more than just a strategyit’s a necessity. With increasing competition, strict regulations, and changing consumer behavior, pharmaceutical brands must embrace digital transformation to stay relevant. But how can pharma marketers break through the noise, engage their audience, and see real ROI?
European Pharmaceutical Review
FEBRUARY 25, 2025
Scientists have developed a new, potentially safer method to produce ethylene oxide. Based on the proposed technique, adding small amounts of nickel atoms to silver catalysts can maintain production efficiency while eliminating the need for chlorine, leading to a reduced environmental impact for ethylene oxide manufacturing. What sparked this development?
The Checkup by Singlecare
FEBRUARY 11, 2025
Meloxicam , sold under the brand name Mobic, is a prescription nonsteroidal anti-inflammatory drug ( NSAID ) used to treat inflammatory conditions like rheumatoid arthritis and osteoarthritis. It is also used off-label (for a use not approved by the Food and Drug Administration) to treat ankylosing spondylitis. Meloxicam is a stronger painkiller than other NSAIDs like ibuprofen and naproxen.
Pharmafile
FEBRUARY 3, 2025
FlyPharma, the leading platform for the pharmaceutical logistics and supply chain industry, is thrilled to announce its ninth European conference, which will take place in Amsterdam from October 8-9, 2025. The FlyPharma Amsterdam 2025 conference will convene industry experts to explore the unique challenges and opportunities facing the region and beyond.
Expert insights. Personalized for you.
184 
Let's personalize your content